advertisement
Liebmann JM 64
Showing records 1 to 25 | Display all abstracts from Liebmann JM109638 What is the Optimal Frequency of Visual Field Testing to Detect Rapid Progression Among Hypertensive Eyes?
Melchior B
Journal of Glaucoma 2023; 32: 721-724
109200 A potential primary endpoint for clinical trials in glaucoma neuroprotection
De Moraes CG
Scientific reports 2023; 13: 7098
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Wu JH
Journal of Glaucoma 2023; 32: 549-555
109624 Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study
Leshno A
Ophthalmology. Glaucoma 2023; 6: 592-598
110002 Identifying Rapid Glaucoma Progression Using Hemifield Rates of Progression
Leshno A
Journal of Glaucoma 2023; 0:
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Leshno A
Eye 2023; 0:
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Moghimi S
American Journal of Ophthalmology 2023; 252: 295-305
109859 Clinical Factors Associated With Long-Term OCT Variability in Glaucoma
Wu JH
American Journal of Ophthalmology 2023; 255: 98-106
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Moghimi S
Journal of Glaucoma 2023; 32: 549-555
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Tsamis E
Eye 2023; 0:
110002 Identifying Rapid Glaucoma Progression Using Hemifield Rates of Progression
Li JX
Journal of Glaucoma 2023; 0:
109624 Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study
De Moraes CG
Ophthalmology. Glaucoma 2023; 6: 592-598
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Kamalipour A
American Journal of Ophthalmology 2023; 252: 295-305
109859 Clinical Factors Associated With Long-Term OCT Variability in Glaucoma
Moghimi S
American Journal of Ophthalmology 2023; 255: 98-106
109638 What is the Optimal Frequency of Visual Field Testing to Detect Rapid Progression Among Hypertensive Eyes?
De Moraes CG
Journal of Glaucoma 2023; 32: 721-724
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Tsamis E
Eye 2023; 0:
109200 A potential primary endpoint for clinical trials in glaucoma neuroprotection
Lane KJ
Scientific reports 2023; 13: 7098
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Tsamis E
Eye 2023; 0:
109200 A potential primary endpoint for clinical trials in glaucoma neuroprotection
Wang X
Scientific reports 2023; 13: 7098
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Nishida T
American Journal of Ophthalmology 2023; 252: 295-305
109859 Clinical Factors Associated With Long-Term OCT Variability in Glaucoma
Walker E
American Journal of Ophthalmology 2023; 255: 98-106
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Harizman N
Eye 2023; 0:
109624 Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study
Cioffi GA
Ophthalmology. Glaucoma 2023; 6: 592-598
109859 Clinical Factors Associated With Long-Term OCT Variability in Glaucoma
Walker E
American Journal of Ophthalmology 2023; 255: 98-106
109638 What is the Optimal Frequency of Visual Field Testing to Detect Rapid Progression Among Hypertensive Eyes?
Paula JS
Journal of Glaucoma 2023; 32: 721-724
